Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled salbutamol for transient tachypnoea of the newborn
IRCT20190328043133N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of salbutamol in transient tachypnea of the newborn (TTN), sponsored by Iran University of Medical Sciences. Started Nov 2022; status: completed.
02
Drugs
salbutamol
03
Conditions
transient tachypnea of the newborn (TTN)
Beyond the preview
Go deeper on IRCT20190328043133N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190328043133N1.